249 related articles for article (PubMed ID: 23962719)
1. Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell lines.
Li T; Chen H; Li W; Cui J; Wang G; Hu X; Hoffman AR; Hu J
Hum Mol Genet; 2014 Jan; 23(1):117-28. PubMed ID: 23962719
[TBL] [Abstract][Full Text] [Related]
2. Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon cancer cells.
Wang H; Ge S; Qian G; Li W; Cui J; Wang G; Hoffman AR; Hu JF
Exp Cell Res; 2015 Nov; 338(2):214-21. PubMed ID: 26407907
[TBL] [Abstract][Full Text] [Related]
3. CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop.
Li T; Hu JF; Qiu X; Ling J; Chen H; Wang S; Hou A; Vu TH; Hoffman AR
Mol Cell Biol; 2008 Oct; 28(20):6473-82. PubMed ID: 18662993
[TBL] [Abstract][Full Text] [Related]
4. Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II.
Zhang H; Niu B; Hu JF; Ge S; Wang H; Li T; Ling J; Steelman BN; Qian G; Hoffman AR
J Cell Biol; 2011 May; 193(3):475-87. PubMed ID: 21536749
[TBL] [Abstract][Full Text] [Related]
5. CTCF is the master organizer of domain-wide allele-specific chromatin at the H19/Igf2 imprinted region.
Han L; Lee DH; Szabó PE
Mol Cell Biol; 2008 Feb; 28(3):1124-35. PubMed ID: 18039862
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.
Yang Y; Hu JF; Ulaner GA; Li T; Yao X; Vu TH; Hoffman AR
J Cell Biochem; 2003 Dec; 90(5):1038-55. PubMed ID: 14624463
[TBL] [Abstract][Full Text] [Related]
7. Induced DNA demethylation can reshape chromatin topology at the IGF2-H19 locus.
Ito Y; Nativio R; Murrell A
Nucleic Acids Res; 2013 May; 41(10):5290-302. PubMed ID: 23585276
[TBL] [Abstract][Full Text] [Related]
8. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
[TBL] [Abstract][Full Text] [Related]
9. CTCF-dependent chromatin bias constitutes transient epigenetic memory of the mother at the H19-Igf2 imprinting control region in prospermatogonia.
Lee DH; Singh P; Tsai SY; Oates N; Spalla A; Spalla C; Brown L; Rivas G; Larson G; Rauch TA; Pfeifer GP; Szabó PE
PLoS Genet; 2010 Nov; 6(11):e1001224. PubMed ID: 21124827
[TBL] [Abstract][Full Text] [Related]
10. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.
Li T; Vu TH; Ulaner GA; Littman E; Ling JQ; Chen HL; Hu JF; Behr B; Giudice L; Hoffman AR
Mol Hum Reprod; 2005 Sep; 11(9):631-40. PubMed ID: 16219628
[TBL] [Abstract][Full Text] [Related]
11. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.
Ulaner GA; Yang Y; Hu JF; Li T; Vu TH; Hoffman AR
Endocrinology; 2003 Oct; 144(10):4420-6. PubMed ID: 12960026
[TBL] [Abstract][Full Text] [Related]
12. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
[TBL] [Abstract][Full Text] [Related]
13. CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors.
Zhang Y; Hu JF; Wang H; Cui J; Gao S; Hoffman AR; Li W
Oncotarget; 2017 May; 8(21):34177-34190. PubMed ID: 27486969
[TBL] [Abstract][Full Text] [Related]
14. Mutation of a single CTCF target site within the H19 imprinting control region leads to loss of Igf2 imprinting and complex patterns of de novo methylation upon maternal inheritance.
Pant V; Kurukuti S; Pugacheva E; Shamsuddin S; Mariano P; Renkawitz R; Klenova E; Lobanenkov V; Ohlsson R
Mol Cell Biol; 2004 Apr; 24(8):3497-504. PubMed ID: 15060168
[TBL] [Abstract][Full Text] [Related]
15. CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2.
Kurukuti S; Tiwari VK; Tavoosidana G; Pugacheva E; Murrell A; Zhao Z; Lobanenkov V; Reik W; Ohlsson R
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10684-9. PubMed ID: 16815976
[TBL] [Abstract][Full Text] [Related]
16. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
Ulaner GA; Vu TH; Li T; Hu JF; Yao XM; Yang Y; Gorlick R; Meyers P; Healey J; Ladanyi M; Hoffman AR
Hum Mol Genet; 2003 Mar; 12(5):535-49. PubMed ID: 12588801
[TBL] [Abstract][Full Text] [Related]
17. A novel pathway links oxidative stress to loss of insulin growth factor-2 (IGF2) imprinting through NF-κB activation.
Yang B; Wagner J; Damaschke N; Yao T; Wuerzberger-Davis SM; Lee MH; Svaren J; Miyamoto S; Jarrard DF
PLoS One; 2014; 9(2):e88052. PubMed ID: 24558376
[TBL] [Abstract][Full Text] [Related]
18. Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells.
Vu TH; Nguyen AH; Hoffman AR
Hum Mol Genet; 2010 Mar; 19(5):901-19. PubMed ID: 20015958
[TBL] [Abstract][Full Text] [Related]
19. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
[TBL] [Abstract][Full Text] [Related]
20. Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate.
Fu VX; Dobosy JR; Desotelle JA; Almassi N; Ewald JA; Srinivasan R; Berres M; Svaren J; Weindruch R; Jarrard DF
Cancer Res; 2008 Aug; 68(16):6797-802. PubMed ID: 18701505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
